These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18928177)

  • 1. [Therapy of lupus nephritis with mycophenolate mofetil].
    Celić D; Ilić T; Durdević-Mirković T; Mitić I; Milić B; Curić S
    Med Pregl; 2007; 60 Suppl 2():124-7. PubMed ID: 18928177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of lupus nephritis with mycophenolate mofetil].
    Celić D; Ilić T; Durdević-Mirković T; Mitić I; Milić B; Curić S
    Med Pregl; 2008; 61(5-6):270-3. PubMed ID: 19102074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.
    Chan TM; Li FK; Tang CS; Wong RW; Fang GX; Ji YL; Lau CS; Wong AK; Tong MK; Chan KW; Lai KN
    N Engl J Med; 2000 Oct; 343(16):1156-62. PubMed ID: 11036121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis.
    Lanata CM; Mahmood T; Fine DM; Petri M
    Lupus; 2010 Jul; 19(8):935-40. PubMed ID: 20388722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of a mycophenolate mofetil-refractory proliferative lupus nephritis with Belimumab in a 19-year-old woman.
    Fließer EE; Korsten P; Koziolek MJ; Niewold TB; Patschan D; Müller GA; Patschan SA
    Lupus; 2013 Dec; 22(14):1523-5. PubMed ID: 24014569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
    Ginzler EM; Dooley MA; Aranow C; Kim MY; Buyon J; Merrill JT; Petri M; Gilkeson GS; Wallace DJ; Weisman MH; Appel GB
    N Engl J Med; 2005 Nov; 353(21):2219-28. PubMed ID: 16306519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil as the primary treatment of membranous lupus nephritis with and without concurrent proliferative disease: a retrospective study of 29 cases.
    Kasitanon N; Petri M; Haas M; Magder LS; Fine DM
    Lupus; 2008 Jan; 17(1):40-5. PubMed ID: 18089682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential therapies for proliferative lupus nephritis.
    Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
    N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mycophenolate mofetil in lupus nephritis].
    Alvarez L; Rivera F; Gil CM; Jiménez del Cerro LA; Olivares J
    Nefrologia; 2002; 22(1):24-32. PubMed ID: 11987681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study.
    Boletis JN; Marinaki S; Skalioti C; Lionaki SS; Iniotaki A; Sfikakis PP
    Nephrol Dial Transplant; 2009 Jul; 24(7):2157-60. PubMed ID: 19179411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis.
    F L; Y T; X P; L W; H W; Z S; H Z; Z H;
    Lupus; 2008 Jul; 17(7):622-9. PubMed ID: 18625634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
    Choi CB; Won S; Bae SC
    Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lupus nephritis: treatment with mycophenolate mofetil.
    Kapitsinou PP; Boletis JN; Skopouli FN; Boki KA; Moutsopoulos HM
    Rheumatology (Oxford); 2004 Mar; 43(3):377-80. PubMed ID: 14963204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis.
    Walsh M; James M; Jayne D; Tonelli M; Manns BJ; Hemmelgarn BR
    Clin J Am Soc Nephrol; 2007 Sep; 2(5):968-75. PubMed ID: 17702723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors for low rate of remission in a population of Colombian patients with severe proliferative lupus nephritis.
    Pinto-Peñaranda LF; Duque-Caballero V; Márquez-Hernández JD; Muñoz-Grajales C; Velásquez-Franco CJ
    Clin Rheumatol; 2015 May; 34(5):897-903. PubMed ID: 25592376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.
    Dooley MA; Jayne D; Ginzler EM; Isenberg D; Olsen NJ; Wofsy D; Eitner F; Appel GB; Contreras G; Lisk L; Solomons N;
    N Engl J Med; 2011 Nov; 365(20):1886-95. PubMed ID: 22087680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction therapy for pediatric focal proliferative lupus nephritis: cyclophosphamide versus mycophenolate mofetil.
    Lau KK; Ault BH; Jones DP; Butani L
    J Pediatr Health Care; 2008; 22(5):282-8. PubMed ID: 18761229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interest of mycophenolate mofetil in children with membranous lupus nephritis].
    Gargah T; Goucha-Louzir R; Lakhoua MR
    Nephrol Ther; 2010 Dec; 6(7):564-8. PubMed ID: 20829140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis.
    Ong LM; Hooi LS; Lim TO; Goh BL; Ahmad G; Ghazalli R; Teo SM; Wong HS; Tan SY; Shaariah W; Tan CC; Morad Z
    Nephrology (Carlton); 2005 Oct; 10(5):504-10. PubMed ID: 16221103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy.
    Karim MY; Pisoni CN; Ferro L; Tungekar MF; Abbs IC; D'Cruz DP; Khamashta MA; Hughes GR
    Rheumatology (Oxford); 2005 Oct; 44(10):1317-21. PubMed ID: 16049051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.